BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 01/11/2019

FDA Announces Draft Guidance for Chronic Hepatitis D Virus Infection Treatment

The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for chronic hepatitis D virus infection, aiming to provide consistent advice on drug development strategies.

Source: Federal Register — Food and Drug AdministrationOpen original release →